Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RKDA Arcadia Biosciences

Not Yet Opened 06-24 16:00:00 EDT

0.6705

-0.0510

-7.07%

盘后0.6705

+0.00000.00%

19:42 EDT

High0.7400	Low0.6510	Vol85.75K
Open0.7201	D1 Closing0.7215	Amplitude12.34%
Mkt Cap3.98M	Tradable Cap3.79M	Total Shares5.94M
T/O60.86K	T/O Rate1.52%	Tradable Shares5.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RKDA","market":"US","secType":"STK","nameCN":"Arcadia Biosciences","latestPrice":0.6705,"timestamp":1782331200000,"preClose":0.7215,"halted":0,"volume":85749,"hourTrading":{"tag":"盘后","latestPrice":0.6705,"preClose":0.6705,"latestTime":"19:42 EDT","volume":145,"amount":95.732,"timestamp":1782344575147,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07068607068607075,"floatShares":5655200,"shares":5940400,"eps":-5.72,"marketStatus":"Not Yet Opened","change":-0.051,"latestTime":"06-24 16:00:00 EDT","open":0.7201,"high":0.74,"low":0.651,"amount":60861.9133818,"amplitude":0.123354,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.72,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782374400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1431662400000,"exchange":"NASDAQ","adjPreClose":0.7215,"preHourTrading":{"tag":"盘前","latestPrice":0.72,"preClose":0.7215,"latestTime":"09:19 EDT","volume":188,"amount":134.7040116,"timestamp":1782307190327,"change":-0.0015,"changeRate":-0.002079,"amplitude":0.009841},"postHourTrading":{"tag":"盘后","latestPrice":0.6705,"preClose":0.6705,"latestTime":"19:42 EDT","volume":145,"amount":95.732,"timestamp":1782344575147,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.704652,"impliedVol":3.7687,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/RKDA/wiki","defaultTab":"wiki","newsList":[{"id":"2643020297","title":"Arcadia Biosciences Announces $4 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2643020297","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643020297?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:58","pubTimestamp":1781539120,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences ( ($RKDA) ) has issued an update. On June 11, 2026, Arcadia Biosciences entered into a securities purchase agreement with an in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arcadia-biosciences-announces-4-million-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arcadia-biosciences-announces-4-million-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643219320","title":"Arcadia Biosciences (Rkda) Announces Closing of $4 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2643219320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643219320?lang=en_us&edition=fundamental","pubTime":"2026-06-13 10:00","pubTimestamp":1781316000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nTUA1HDNGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642302052","title":"Arcadia Biosciences prices USD 4 million at-the-market private placement at USD 1.03 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2642302052","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642302052?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:00","pubTimestamp":1781222421,"startTime":"0","endTime":"0","summary":"Deal includes 3,883,496 common shares or pre-funded warrants, with Series A-1 and Series A-2 preferred investment options for 3,883,496 shares each.Preferred investment options carry a USD 0.91 exercise price; A-1 expires five years post-stockholder approval, A-2 expires 24 months after a resale registration statement.Closing expected June 12, 2026; H.C. Wainwright is placement agent.Proceeds earmarked for working capital, general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9wFgPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014039.USD","BK4189","LU2210150020.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","RKDA","LU2210149790.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","NDAQ","SG9999014021.USD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","IE00BN0W2V16.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642230279","title":"Press Release: Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2642230279","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642230279?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:00","pubTimestamp":1781222400,"startTime":"0","endTime":"0","summary":"DALLAS, June 11, 2026  -- Arcadia Biosciences, Inc. , a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock , Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock  and associated preferred investment options in a private placement priced at-the-market under Nasdaq rules.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the sec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4189","BK4232","NQmain","RKDA","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636862816","title":"Top News Today: Stocks Fall, Treasury Yields Rise on Inflation Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2636862816","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636862816?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:37","pubTimestamp":1779223020,"startTime":"0","endTime":"0","summary":"TREASURYS: Treasury yields rose to their highs of the year due to inflation and anticipated central-bank responses.COMMODITIES: Oil futures slipped, but held near $108 a barrel in New York, as traders awaited updates from U.S.-Iran negotiations.Iran's position in talks with the U.S. to end the war hasn't changed much from earlier iterations that failed to yield progress toward a deal, regional mediators and U.S. officials familiar with the terms said, raising questions about whether an offramp to the conflict can be found.The comments came after President Trump said he had called off military strikes planned for Tuesday in light of what he called positive developments at the negotiating table.Andrej Karpathy, Tesla Alum and OpenAI Co-Founder, Joins Anthropic. The company has started rolling out what it calls Gemini Spark, a personal agent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YMAG","CRVL","LU1400636491.USD","ENS","LU0048584097.USD","GOOW","BK4612","GOU","CLIR","GGLS","LU0477156797.USD","LU2420271590.USD","GGLL","RKDA","LU2487616109.SGD","MAGY","LU0251132253.USD","IE00B19Z3B42.SGD","LU2404859667.USD","ADI","LU0006306889.USD","LU0267386448.USD","LU0210528500.USD","LU1935042215.USD","LU2462157665.USD","GOOY","GOOP","LU1196500208.SGD","ACGP","LU1366333091.USD","LU0124384867.USD","BK4503","LU0215105999.USD","LU0149725797.USD","LPG","LU0345769128.USD","LU1951198990.SGD","LU2242649171.HKD","LU2404859741.USD","LU0107464264.USD","GB00B4LPDJ14.GBP","LU1923622614.USD","LU0158827948.USD","GOOX","LU0426412945.USD","BK4161","HK0000819398.USD","GOOGL","IE00BKDWB100.SGD","AMSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726088","title":"Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726088","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726088?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:53","pubTimestamp":1778792024,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.11) per share which missed the analyst consensus estimate of $(0.80) by 163.75 percent. This is a 211.05 percent decrease over earnings of $1.90 per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52583215/arcadia-biosciences-q1-eps-2-11-misses-0-80-estimate-sales-1-100m-miss-1-600m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723773","title":"Arcadia Biosciences Q1 FY26 net loss widens to $4.39 million; revenue falls 8% to $1.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723773","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723773?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:13","pubTimestamp":1778789624,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences reported a net loss attributable to common stockholders of USD 4.39 million, swinging from net income of USD 2.6 million a year earlier.Revenue fell 8% to USD 1.1 million, while operating results swung to an operating loss of USD 779,000.Other loss widened to USD 1.5 million, driven primarily by an unrealized loss recognized subsequent to receipt of AFII common stock.Cash and cash equivalents totaled USD 1 million at March 31, 2026, and the company said existing cash will not be sufficient to meet anticipated cash requirements for at least the next 12 months, raising substantial doubt about its ability to continue as a going concern.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL3TZdJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723668","title":"BRIEF-Arcadia Biosciences Q1 Net Income USD -4.385 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723668","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723668?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789150,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Q1 Net Income USD -4.385 Million\n\n\nMay 14 (Reuters) - Arcadia Biosciences Q1 revenue USD 1.1 million.\n\nQ1 operating expenses USD 1.879 million\nQ1 EPS USD -2.11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX6B6B78:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635072338","title":"Arcadia Biosciences Q1 Operating Expenses USD 1.879 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635072338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635072338?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX6B6B78:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725523","title":"Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725523","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725523?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789100,"startTime":"0","endTime":"0","summary":"-- Zola volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May  14, 2026  (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marke","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295353/35730/en/Arcadia-Biosciences-RKDA-Announces-First-Quarter-2026-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624661176","title":"Arcadia Biosciences dismisses Deloitte, names Ramirez Jimenez International as new auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2624661176","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624661176?lang=en_us&edition=fundamental","pubTime":"2026-04-04 03:31","pubTimestamp":1775244710,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Audit Committee dismissed Deloitte & Touche as independent auditor on March 30, 2026.Deloitte audit reports for fiscal 2025 and 2024 included a going-concern explanatory paragraph tied to accumulated deficit, recurring losses, cash burn.Company disclosed material weaknesses in internal control over financial reporting as of Dec. 31, 2025, citing reduced headcount that weakened segregation of duties and IT access controls.Ramirez Jimenez International CPAs was engaged as successor auditor effective March 30, 2026, starting with review of quarter ended March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL8gDQGx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896491","title":"Arcadia Biosciences FY2025 net loss attributable to common stockholders narrows 67% to $2.3 million; revenue drops 4% to $4.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896491?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:09","pubTimestamp":1774555764,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences FY2025 net loss attributable to common stockholders narrows 67% to $2.3 million; revenue drops 4% to $4.9 million. Arcadia Biosciences filed a Form 8-K reporting Q4 and FY 2025 results, including Q4 total revenues of 901,000 USD, down 26%.FY total revenues were 4.86 million USD, down 4%, as higher Zola revenues were offset by no GLA oil sales.Q4 net loss attributable to common stockholders was 1.34 million USD, compared with a net loss of 4.06 million USD a year earlier.FY net loss attributable to common stockholders was 2.34 million USD, compared with a net loss of 7.04 million USD a year earlier.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3JrVxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622922896","title":"BRIEF-Arcadia Biosciences Q4 Net Income USD -1.336 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622922896","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622922896?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555546,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Q4 Net Income USD -1.336 Million\n\n\nMar 26 (Reuters) - Arcadia Biosciences Q4 operating expenses USD 2.276 million.\n\nQ4 revenue USD 901 thousand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX9CA113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622889165","title":"Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2622889165","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622889165?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"-- Zola revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination -- -- Exercise of preferred investment options yields $2.1 million gross proc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263397/35730/en/Arcadia-Biosciences-RKDA-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609113635","title":"Zwei Vorstandsmitglieder von Arcadia Biosciences Inc. treten zurück","url":"https://stock-news.laohu8.com/highlight/detail?id=2609113635","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609113635?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:04","pubTimestamp":1770411879,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. hat bekannt gegeben, dass Albert D. Bolles, Ph.D., und Deborah Carosella mit Wirkung zum 4. Februar 2026 aus dem Vorstand des Unternehmens ausgeschieden sind. Beide werden dem Unternehmen weiterhin beratend zur Verfügung stehen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL4MCZVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606718590","title":"Arcadia Biosciences files to sell 1.67M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2606718590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606718590?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:10","pubTimestamp":1769598622,"startTime":"0","endTime":"0","summary":"06:09 EST Arcadia Biosciences (RKDA) files to sell 1.67M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcadia-biosciences-files-to-sell-1-67m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcadia-biosciences-files-to-sell-1-67m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603618887","title":"BRIEF-Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603618887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603618887?lang=en_us&edition=fundamental","pubTime":"2026-01-14 19:41","pubTimestamp":1768390900,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors  - SEC FilingJan 14  - SEC Filing:ARCADIA BIOSCIENCES INC - ENTERS INDUCEMENT OFFER LETTER AGREEMENTS WITH CERTAIN INVESTORS  - SEC FILINGARCADIA BIOSCIENCES INC - INVESTORS TO PURCHASE 808,595 SHARES OF OF THE CO'S COMMON STOCK- SEC FILINGSource text: [ID:n0001193125-26-012028]Further company coverage: RKDA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602510833","title":"Arcadia Biosciences Raises $2.1 Million Through Exercise of Preferred Investment Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510833","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510833?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:01","pubTimestamp":1768222898,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. announced the immediate exercise of certain outstanding preferred investment options, allowing the purchase of up to 808,595 shares of common stock at a reduced exercise price of $2.575 per share, down from the original $9.00 per share. The company expects to receive approximately $2.1 million in gross proceeds from this transaction, before deducting placement agent fees and offering expenses. In connection with this exercise, Arcadia will also issue new unregistered preferred investment options to purchase up to 1,617,190 shares of common stock at an exercise price of $2.325 per share. These new options are immediately exercisable and will expire thirty months after the effective date of a forthcoming resale registration statement. Net proceeds will be used for working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8sGFDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","BK4112","RKDA","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","SG9999014021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594574299","title":"Arcadia Biosciences Receives Notice of Termination for Roosevelt Resources Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2594574299","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594574299?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:02","pubTimestamp":1766754131,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences has received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between the two companies that was originally signed on December 4, 2024. The agreement had provided for a proposed business combination. Following the termination, Arcadia plans to resume evaluating strategic alternatives, citing its streamlined operations, reduced expenses, ownership of shares in Above Food Ingredients Inc., and ongoing growth of the Zola coconut water brand as assets that may support future transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire  on December 26, 2025, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nNDL92mxs4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4212","SG9999014005.SGD","LU0314104364.USD","BK4112","BK4588","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4189","LU2210149790.SGD","IE00BKPKM429.USD","RKDA","SG9999014013.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","ABVE","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594995792","title":"Arcadia Biosciences (Rkda) Receives Termination Notice of the Proposed Business Combination With Roosevelt Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2594995792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594995792?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:02","pubTimestamp":1766754120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nTUA557V83:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcadiabio.com","stockEarnings":[{"period":"1week","weight":-0.1989},{"period":"1month","weight":-0.2707},{"period":"3month","weight":-0.5589},{"period":"6month","weight":-0.7421},{"period":"1year","weight":-0.8459},{"period":"ytd","weight":-0.6614}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.034513},{"month":2,"riseRate":0.363636,"avgChangeRate":0.0867},{"month":3,"riseRate":0.181818,"avgChangeRate":0.26799},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.0932},{"month":5,"riseRate":0.454545,"avgChangeRate":0.033099},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.107613},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.110678},{"month":8,"riseRate":0.545455,"avgChangeRate":0.235192},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.198577},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.040169},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.084204},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.016763}],"exchange":"NASDAQ","name":"Arcadia Biosciences","nameEN":"Arcadia Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Arcadia Biosciences(RKDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Arcadia Biosciences,RKDA,Arcadia Biosciences股票,Arcadia Biosciences股票老虎,Arcadia Biosciences股票老虎国际,Arcadia Biosciences行情,Arcadia Biosciences股票行情,Arcadia Biosciences股价,Arcadia Biosciences股市,Arcadia Biosciences股票价格,Arcadia Biosciences股票交易,Arcadia Biosciences股票购买,Arcadia Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Arcadia Biosciences(RKDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}